An observational, retrospective trial to evaluate the efficacy and safety of low-dose etanercept in patients with ankylosing spondylitis

Trial Profile

An observational, retrospective trial to evaluate the efficacy and safety of low-dose etanercept in patients with ankylosing spondylitis

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 Apr 2016

At a glance

  • Drugs Etanercept (Primary)
  • Indications Ankylosing spondylitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Apr 2016 New trial record
    • 25 Mar 2016 Results (n=134) published in the Clinical and Experimental Rheumatology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top